Search This Blog

Thursday, February 27, 2020

Acceleron Pharma EPS misses by $0.09, beats on revenue

Acceleron Pharma (NASDAQ:XLRN): Q4 GAAP EPS of -$0.44 misses by $0.09.
Revenue of $39.34M (+929.8% Y/Y) beats by $3.45M.
Press Release
https://seekingalpha.com/news/3546682-acceleron-pharma-eps-misses-0_09-beats-on-revenue
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)